Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azanplus
2. Gr 122311x
3. Gr-122311x
4. Gr122311x
5. Pylorid
6. Raniberl
7. Tritec
1. Ranitidine Bismutrex
2. Tritec
3. Gr 122311x
4. Gr-122311x
5. 7aj51i17kg
6. 128345-62-0
7. Ranitidine (bismuth Citrate)
8. Azamplus
9. Elicodil
10. Helirad
11. Pylorisan
12. Unii-7aj51i17kg
13. Ranitidine Bismuth Citrate [usan]
14. Ranitidine Bismuth Citrate [usan:ban]
15. Schembl415304
16. Chembl2111286
17. Dtxsid801027716
18. Ranitidine Bismuth Citrate [mi]
19. N-(2-((5-((dimethylamino)methyl)furfuryl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine, Compound With Bismuth(3(+)) Citrate (1:1)
20. Ranitidine Bismuth Citrate [vandf]
21. Ranitidine Bismuth Citrate [mart.]
22. Ranitidine Bismuth Citrate [who-dd]
23. Ranitidine Bismuth Citrate [orange Book]
24. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3(+)) Salt (1:1), Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1)
25. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt (1:1), Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1)
26. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt, Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1:1)
27. N-(2-((5-((dimethylamino)methyl)furfuryl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine, Compound With Bismuth(3+) Citrate (1:1)
| Molecular Weight | 712.5 g/mol |
|---|---|
| Molecular Formula | C19H27BiN4O10S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 11 |
| Exact Mass | 712.12519 g/mol |
| Monoisotopic Mass | 712.12519 g/mol |
| Topological Polar Surface Area | 252 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 558 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 3 |
Histamine H2 Antagonists
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BA - H2-receptor antagonists
A02BA07 - Ranitidine bismuth citrate
Digital Content 
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
A Ranitidine Bismuth Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ranitidine Bismuth Citrate, including repackagers and relabelers. The FDA regulates Ranitidine Bismuth Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ranitidine Bismuth Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ranitidine Bismuth Citrate supplier is an individual or a company that provides Ranitidine Bismuth Citrate active pharmaceutical ingredient (API) or Ranitidine Bismuth Citrate finished formulations upon request. The Ranitidine Bismuth Citrate suppliers may include Ranitidine Bismuth Citrate API manufacturers, exporters, distributors and traders.
Ranitidine Bismuth Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ranitidine Bismuth Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ranitidine Bismuth Citrate GMP manufacturer or Ranitidine Bismuth Citrate GMP API supplier for your needs.
A Ranitidine Bismuth Citrate CoA (Certificate of Analysis) is a formal document that attests to Ranitidine Bismuth Citrate's compliance with Ranitidine Bismuth Citrate specifications and serves as a tool for batch-level quality control.
Ranitidine Bismuth Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Ranitidine Bismuth Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ranitidine Bismuth Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ranitidine Bismuth Citrate EP), Ranitidine Bismuth Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ranitidine Bismuth Citrate USP).
LOOKING FOR A SUPPLIER?
